Pharma Giants Compete Intensely over Metsera Acquisition and the Weight-Loss Drug RaceBusiness PenOctober 30, 2025 October 30, 2025 In a move that has escalated competition in the growing obesity treatment market, Danish pharmaceutical company Novo Nordisk A/S (NASDAQ: NVO) has made an unsolicited...
